<!DOCTYPE html>
<html lang="en">

<head>
    <!-- Google tag (gtag.js) -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=G-L5GS1G09ML"></script>
    <script>
        window.dataLayer = window.dataLayer || [];
        function gtag() { dataLayer.push(arguments); }
        gtag('js', new Date());
        gtag('config', 'G-L5GS1G09ML');
    </script>

    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    
    <!-- Primary Meta Tags -->
    <title>Survey: 84% of Canadian Sniffies Users Want Rapid HIV PrEP Testing | Abundant Science Research</title>
    <meta name="title" content="Survey: 84% of Canadian Sniffies Users Want Rapid HIV PrEP Testing - June 2025 Study">
    <meta name="description" content="Cross-sectional study of 87 Canadian MSM reveals 84% demand for rapid HIV PrEP testing. Key findings on discretion barriers and Canada's 2030 HIV elimination goals.">
    <meta name="keywords" content="HIV PrEP testing Canada, rapid HIV test, MSM health Canada, Sniffies study, HIV elimination 2030, discreet testing, PrEP monitoring, sexual health research, harm reduction Canada">
    <meta name="author" content="Jay Gerbrandt, Abundant Science">
    <meta name="robots" content="index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1">
    <link rel="canonical" href="https://www.abundantscience.com/blog/2025/06/84-percent-of-sniffies-users-want-rapid-hiv-prep-testing.html">
    
    <!-- Open Graph / Facebook -->
    <meta property="og:type" content="article">
    <meta property="og:url" content="https://www.abundantscience.com/blog/2025/06/84-percent-of-sniffies-users-want-rapid-hiv-prep-testing.html">
    <meta property="og:title" content="84% of Canadian Sniffies Users Want Rapid HIV PrEP Testing">
    <meta property="og:description" content="Groundbreaking study reveals extraordinary demand for rapid HIV PrEP testing among Canadian MSM population.">
    <meta property="og:image" content="https://www.abundantscience.com/images/blog/hiv-prep-study-2025.jpg">
    <meta property="og:image:width" content="1200">
    <meta property="og:image:height" content="630">
    <meta property="og:site_name" content="Abundant Science">
    <meta property="article:published_time" content="2025-06-20T09:00:00-04:00">
    <meta property="article:modified_time" content="2025-06-20T09:00:00-04:00">
    <meta property="article:author" content="Jay Gerbrandt">
    <meta property="article:section" content="Research">
    <meta property="article:tag" content="HIV">
    <meta property="article:tag" content="PrEP">
    <meta property="article:tag" content="Public Health">
    
    <!-- Twitter -->
    <meta property="twitter:card" content="summary_large_image">
    <meta property="twitter:url" content="https://www.abundantscience.com/blog/2025/06/84-percent-of-sniffies-users-want-rapid-hiv-prep-testing.html">
    <meta property="twitter:title" content="84% of Canadian Sniffies Users Want Rapid HIV PrEP Testing">
    <meta property="twitter:description" content="New research reveals extraordinary demand for rapid HIV PrEP testing among Canadian MSM.">
    <meta property="twitter:image" content="https://www.abundantscience.com/images/blog/hiv-prep-study-2025.jpg">
    <meta property="twitter:creator" content="@abundantscience">
    
    <!-- Additional SEO -->
    <meta name="geo.region" content="CA">
    <meta name="geo.placename" content="Toronto, Ontario, Canada">
    <meta name="language" content="English">
    <meta http-equiv="content-language" content="en-CA">
    <meta name="publication_date" content="2025-06-20">
    <meta name="news_keywords" content="HIV, PrEP, rapid testing, MSM, Canada, public health, research">

    <!-- JSON-LD Structured Data -->
    <script type="application/ld+json">
    {
        "@context": "https://schema.org",
        "@graph": [
            {
                "@type": "ScholarlyArticle",
                "@id": "https://www.abundantscience.com/blog/2025/06/84-percent-of-sniffies-users-want-rapid-hiv-prep-testing.html#article",
                "isPartOf": {
                    "@id": "https://www.abundantscience.com/blog/#webpage"
                },
                "author": {
                    "@type": "Person",
                    "name": "Jay Gerbrandt",
                    "identifier": "https://orcid.org/0009-0002-0863-561X",
                    "jobTitle": "Chief Science Officer",
                    "affiliation": {
                        "@id": "https://www.abundantscience.com/#organization"
                    }
                },
                "headline": "Survey: 84% of Canadian Sniffies Users Want Rapid HIV PrEP Testing",
                "alternativeHeadline": "Cross-sectional study reveals extraordinary demand for rapid HIV PrEP testing",
                "datePublished": "2025-06-20T09:00:00-04:00",
                "dateModified": "2025-06-20T09:00:00-04:00",
                "mainEntityOfPage": {
                    "@id": "https://www.abundantscience.com/blog/2025/06/84-percent-of-sniffies-users-want-rapid-hiv-prep-testing.html"
                },
                "wordCount": 1200,
                "publisher": {
                    "@id": "https://www.abundantscience.com/#organization"
                },
                "image": {
                    "@type": "ImageObject",
                    "url": "https://www.abundantscience.com/images/blog/hiv-prep-study-2025.jpg",
                    "width": 1200,
                    "height": 630
                },
                "articleSection": "Research",
                "keywords": "HIV, PrEP, rapid testing, MSM, discretion, public health, Canada",
                "description": "Cross-sectional survey of Canadian Sniffies users reveals 84% demand for rapid HIV PrEP testing with implications for Canada's HIV elimination goals.",
                "about": {
                    "@type": "MedicalStudy",
                    "studySubject": "Rapid HIV PrEP Testing Demand",
                    "studyLocation": {
                        "@type": "Country",
                        "name": "Canada"
                    },
                    "numberOfParticipants": 87,
                    "studyDesign": "Cross-sectional survey"
                }
            },
            {
                "@type": "Dataset",
                "name": "Canadian Sniffies Users HIV PrEP Testing Survey Data",
                "description": "Survey data from 87 Canadian Sniffies users on rapid HIV PrEP testing preferences",
                "creator": {
                    "@id": "https://www.abundantscience.com/#organization"
                },
                "datePublished": "2025-06-20",
                "license": "Available upon request",
                "variableMeasured": [
                    "PrEP testing interest",
                    "Discretion preferences",
                    "Drug testing interest",
                    "Geographic location"
                ]
            },
            {
                "@type": "BreadcrumbList",
                "@id": "https://www.abundantscience.com/blog/2025/06/84-percent-of-sniffies-users-want-rapid-hiv-prep-testing.html#breadcrumb",
                "itemListElement": [
                    {
                        "@type": "ListItem",
                        "position": 1,
                        "name": "Home",
                        "item": "https://www.abundantscience.com/"
                    },
                    {
                        "@type": "ListItem",
                        "position": 2,
                        "name": "Blog",
                        "item": "https://www.abundantscience.com/blog/"
                    },
                    {
                        "@type": "ListItem",
                        "position": 3,
                        "name": "2025",
                        "item": "https://www.abundantscience.com/blog/2025/"
                    },
                    {
                        "@type": "ListItem",
                        "position": 4,
                        "name": "84% Survey Results",
                        "item": "https://www.abundantscience.com/blog/2025/06/84-percent-of-sniffies-users-want-rapid-hiv-prep-testing.html"
                    }
                ]
            },
            {
                "@type": "Organization",
                "@id": "https://www.abundantscience.com/#organization",
                "name": "Abundant Science",
                "url": "https://www.abundantscience.com",
                "logo": {
                    "@type": "ImageObject",
                    "url": "https://www.abundantscience.com/logo-nobackground.jpg"
                },
                "sameAs": [
                    "https://www.tiktok.com/@abundant.science"
                ],
                "contactPoint": {
                    "@type": "ContactPoint",
                    "email": "jay@abundant.science",
                    "contactType": "Research Inquiries",
                    "telephone": "+1-416-333-4829"
                }
            },
            {
                "@type": "NewsArticle",
                "headline": "84% of Canadian Sniffies Users Want Rapid HIV PrEP Testing",
                "datePublished": "2025-06-20T09:00:00-04:00",
                "dateModified": "2025-06-20T09:00:00-04:00",
                "author": {
                    "@type": "Person",
                    "name": "Jay Gerbrandt"
                },
                "publisher": {
                    "@id": "https://www.abundantscience.com/#organization"
                },
                "description": "New research reveals extraordinary demand for rapid HIV PrEP testing among Canadian MSM population",
                "articleBody": "A cross-sectional study of Canadians using the geospatial dating platform Sniffies reveals extraordinary demand for rapid HIV PrEP testing..."
            },
            {
                "@type": "MedicalWebPage",
                "specialty": "HIV Prevention",
                "audience": {
                    "@type": "MedicalAudience",
                    "audienceType": "Researcher"
                },
                "medicalAudience": {
                    "@type": "PeopleAudience",
                    "audienceType": "MSM Population",
                    "geographicArea": {
                        "@type": "Country",
                        "name": "Canada"
                    }
                }
            },
            {
                "@type": "FAQPage",
                "mainEntity": [
                    {
                        "@type": "Question",
                        "name": "What percentage of survey respondents wanted PrEP rapid testing?",
                        "acceptedAnswer": {
                            "@type": "Answer",
                            "text": "84% of respondents expressed interest in PrEP rapid testing (95% CI: 75%–91%), with 100% of non-discreet users wanting PrEP testing."
                        }
                    },
                    {
                        "@type": "Question",
                        "name": "How many people participated in this study?",
                        "acceptedAnswer": {
                            "@type": "Answer",
                            "text": "The study had 87 unique respondents from 747 clicks on advertisements, representing an 11.6% conversion rate with a ±10.6% margin of error at 95% confidence."
                        }
                    },
                    {
                        "@type": "Question",
                        "name": "What are the implications for Canada's HIV elimination strategy?",
                        "acceptedAnswer": {
                            "@type": "Answer",
                            "text": "Platform-based interventions reaching discreet MSM populations could meaningfully contribute to the first '95' (diagnosis) of the 95-95-95 goal while supporting PrEP scale-up efforts."
                        }
                    }
                ]
            },
            {
                "@type": "StatisticalPopulation",
                "name": "Study Population",
                "populationType": "Canadian Sniffies Users",
                "numConstraints": 87,
                "constrainingProperty": [
                    {
                        "@type": "PropertyValue",
                        "name": "Platform",
                        "value": "Sniffies"
                    },
                    {
                        "@type": "PropertyValue",
                        "name": "Country",
                        "value": "Canada"
                    },
                    {
                        "@type": "PropertyValue",
                        "name": "Study Period",
                        "value": "May 15 - June 15, 2025"
                    }
                ]
            }
        ]
    }
    </script>

    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600&display=swap" rel="stylesheet" />
    <link rel="stylesheet" href="../../styles/marketing.css" />
    <link rel="stylesheet" href="../../styles/form.css" />
    <link rel="stylesheet" href="../../styles/campaigns.css" />
    <link rel="stylesheet" href="../../styles/signup.css" />
    <link rel="stylesheet" href="../../styles/home-page.css" />
    <script src="https://cdn.jsdelivr.net/npm/@supabase/supabase-js"></script>
    <script src="/js/supabaseFormHandler.js"></script>

    <style>
        .blog-article-section {
            background-color: #fffcf9;
            padding: 50px 60px;
            border-radius: 8px;
            margin: 20px auto;
            max-width: 90%;
            width: 900px;
            box-sizing: border-box;
            text-align: left;
            font-family: 'Inter', sans-serif;
        }

        .blog-article-section h2 {
            font-size: 32px;
            margin-top: 2rem;
            margin-bottom: 1rem;
            color: #222;
        }

        .blog-article-section h3 {
            font-size: 24px;
            margin-top: 1.5rem;
            margin-bottom: 0.75rem;
            color: #333;
        }

        .blog-article-section p,
        .blog-article-section ul li {
            font-size: 18px;
            line-height: 1.6;
            color: #444;
        }

        .blog-article-section ul {
            margin: 1rem 0;
            padding-left: 2rem;
        }

        .blog-article-section ul li {
            margin-bottom: 0.5rem;
        }

        .blog-badge {
            display: inline-block;
            padding: 5px 10px;
            background-color: #798ff6;
            border: 1px solid #798ff6;
            border-radius: 4px;
            font-size: 14px;
            color: white;
            margin-bottom: 40px;
            font-weight: 600;
        }

        .key-findings {
            background: #f5f8ff;
            padding: 2rem;
            border-radius: 8px;
            margin: 2rem 0;
            border-left: 4px solid #798ff6;
        }

        .key-findings h3 {
            color: #1e3a8a;
            margin-top: 0;
        }

        .statistics-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 1.5rem;
            margin: 2rem 0;
        }

        .stat-card {
            background: white;
            padding: 1.5rem;
            border-radius: 8px;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            text-align: center;
        }

        .stat-card .stat-number {
            font-size: 2rem;
            font-weight: bold;
            color: #1e3a8a;
            display: block;
            margin-bottom: 0.5rem;
        }

        .stat-card .stat-label {
            font-size: 0.9rem;
            color: #666;
        }

        @media (max-width: 768px) {
            .blog-article-section {
                padding: 30px 20px !important;
            }

            .statistics-grid {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div id="nav-placeholder"></div>
    
    <header class="home-hero-section">
        <h1 class="home-title">
            <strong>Rapid Testing Research</strong><br>
            <span style="font-weight:400;">By Abundant Science</span>
        </h1>
    </header>

    <section class="blog-article-section">
        <div class="blog-badge">
            <strong>Press Release</strong>
        </div>

        <h1 style="text-align: center; font-size: 36px;">June 2025 Survey: 84% of Canadian Sniffies Users Want Rapid HIV PrEP Testing</h1>

        <p><strong>Toronto, June 20, 2025</strong> – A cross-sectional study of Canadians using the geospatial dating platform Sniffies (762,699 impressions from May 15–June 15, 2025) reveals extraordinary demand for rapid HIV PrEP testing and personal drug testing supplies, with implications for Canada's 2030 HIV elimination goals and unaddressed populations like discreet MSM.</p>

        <div class="key-findings">
            <h3>Key Findings (n=87, ±10.6% margin of error at 95% confidence)</h3>
            <ul>
                <li><strong>72% identify as "discreet"</strong> (95% CI: 62%–81%) – Sniffies users prioritize boundaries, pointing to systematic gaps in current service delivery without an explicit outreach strategy</li>
                <li><strong>84% want PrEP rapid testing</strong> (95% CI: 75%–91%) – Far exceeding general population awareness rates, suggesting highly activated user base interest in alternative options to lab testing.</li>
                <li><strong>100% of non-discreet users want PrEP rapid testing</strong> (24/24, 95% CI: 85%–100%) — Among "out" users, PrEP rapid testing interest is universal, suggesting discretion may represent an access barrier</li>
                <li><strong>97% overlap between drug supply testing and PrEP rapid test interest</strong> – Of 33 users seeking drug testing, 32 also want PrEP rapid testing, indicating cross distribution opportunity for this sub-segment</li>
                <li><strong>11.6% conversion rate</strong> – High engagement from advertisement to email signup (747 clicks, 87 unique respondents) demonstrates genuine market demand, not passive survey participation</li>
            </ul>
        </div>

        <h3>The Discretion Paradox</h3>
        <p>Strikingly, a key finding challenges assumptions about hard-to-reach populations poorly represented in the corpus of research. While 100% of "non-discreet" users expressed PrEP rapid testing interest, 78% of "discreet" users indicated interest. This suggests privacy needs, not health awareness, may play a bigger part in barriers to ongoing PrEP compliance.</p>

        <p>"We're seeing users who are highly health-conscious but may be structurally excluded by current diagnostics delivery models," said Jay Gerbrandt, Chief Science Officer at Abundant Science and lead researcher. "When every single non-discreet user wants PrEP rapid tests, but only 78% of discreet users show interest, discretion becomes a structural barrier borne of a personal choice to further understand."</p>

        <h3>Market Sizing and Opportunity</h3>
        <p>With 5 of 7 required PrEP tests already Health Canada-approved in rapid form, regulatory barriers appear surmountable. The remaining tests have European approval, suggesting technical feasibility for comprehensive at-home panels.</p>

        <p>Conservative estimates based on study engagement rates suggest 15,000–25,000 potential users across major Canadian markets, representing $3–5M annual market opportunity at current PrEP testing costs.</p>

        <h3>By the Numbers</h3>
        <div class="statistics-grid">
            <div class="stat-card">
                <span class="stat-number">762,699</span>
                <span class="stat-label">Advertisement impressions across two regions</span>
            </div>
            <div class="stat-card">
                <span class="stat-number">87</span>
                <span class="stat-label">Unique respondents (±10.6% margin of error)</span>
            </div>
            <div class="stat-card">
                <span class="stat-number">84%</span>
                <span class="stat-label">Want PrEP rapid testing (95% CI: 75%–91%)</span>
            </div>
            <div class="stat-card">
                <span class="stat-number">100%</span>
                <span class="stat-label">Non-discreet users wanting PrEP testing</span>
            </div>
            <div class="stat-card">
                <span class="stat-number">72%</span>
                <span class="stat-label">Identified as "discreet" (95% CI: 62%–81%)</span>
            </div>
            <div class="stat-card">
                <span class="stat-number">38%</span>
                <span class="stat-label">Wanted drug testing supplies (95% CI: 28%–49%)</span>
            </div>
        </div>

        <h3>Geographic Disparities</h3>
        <p>Prairie users showed 52% higher conversion rates (13.4% vs 8.83%) despite mixed rural-urban coverage, suggesting underserved regions are more responsive to novel access methods. This supports targeting rapid testing solutions to areas with limited traditional sexual health infrastructure. Continued research in different densities will provide more insight into distribution access.</p>

        <h3>Public Health Implications</h3>
        <p>Canada's HIV elimination strategy requires reaching approximately 7,000 undiagnosed individuals – 11% of people living with HIV. Platform-based interventions reaching discreet MSM populations could meaningfully contribute to the first "95" (diagnosis) of the 95-95-95 goal while supporting PrEP scale-up efforts.</p>

        <p>The 97% correlation between party-and-play (PnP) substance use and associated drug testing and PrEP rapid testing interest illuminates critical intersections between harm reduction and HIV prevention, supporting integrated service delivery models which could be integrated into existing deployment systems via expanded telehealth for both clinical and rapid testing purposes.</p>

        <h3>Study Methodology</h3>
        <p>This cross-sectional survey employed advertising-based recruitment on Sniffies from May 15–June 15, 2025, using sequential geographic deployment: Prairie provinces (May 15–June 8) followed by major coastal cities (June 9–15). Advertisements appeared across four platform placement zones, achieving 762,699 impressions and 747 clicks.</p>

        <p>Participants completed a secure web form at abundant.science/free-hiv-rapid-test indicating interest in: discretion ("Your email won't say HIV in it"), PrEP rapid testing, and drug testing supplies. The study collected 87 unique email addresses (11.6% conversion rate) with no personal health information beyond self-reported interests.</p>

        <p><strong>Limitations:</strong> Convenience sampling introduces selection biases limiting generalizability. Small sample sizes preclude robust statistical inference for subgroup comparisons. Results represent market signals rather than precise population conclusions.</p>

        <p><strong>Ethics:</strong> Research conducted in accordance with Canadian privacy legislation (PIPEDA, PHIPA). Informed consent obtained through web form submission with clear data use disclosure.</p>

        <h3>Next Steps</h3>
        <p>Results will inform development of Canada and the world's first comprehensive rapid PrEP testing panel. Abundant Science is exploring partnerships with private financing, provincial health authorities and harm reduction organizations to scale privacy-preserving testing solutions.</p>

        <p>Abundant Science is drafting a pre-print and whitepaper. After engagement and refinement, Gerbrandt plans to submit the research for peer review and publication in a Canadian medical journal, while advancing product development based on this demonstrated market demand.</p>

        <h3>About the Research</h3>
        <p>This market validation study was conducted by Abundant Science Inc., a Toronto-based, Canadian owned and operated independent company developing rapid testing solutions for Canadian healthcare markets. Full methodology and anonymized data available upon request via <a href="https://abundantscience.com">https://abundantscience.com</a>.</p>

        <p><strong>Media Contact:</strong><br>
        Jay Gerbrandt, Chief Science Officer<br>
        ORCid: <a href="https://orcid.org/0009-0002-0863-561X">0009-0002-0863-561X</a><br>
        Email: <a href="mailto:jay@abundant.science">jay@abundant.science</a><br>
        Phone: 416 333 4829</p>
    </section>

    <div id="footer-placeholder"></div>
    <script src="../../scripts/template-loader.js"></script>
    <script src="../../scripts/component-loader.js"></script>
</body>

</html>
